Insights / Technology
Posts carrying the Synthetic Data tag.
19 Feb 2026 · 2 min read
Two pharma-AI deals in two weeks, two completely different architectures. Takeda paid $1.7B for Iambic. Now Merck skips techbio entirely and runs its AI models inside Mayo Clinic’s secure data environment. The architecture behind the Merck deal is what matters.
4 Nov 2025 · 1 min read
Eli Lilly just moved from renting compute to owning it — 1,000+ Blackwell B300 GPUs in an on-prem DGX SuperPOD in Indianapolis. Their TuneLab initiative could turn R&D IT from a cost center into a deal channel, and it's further proof that pharma is finally taking AI seriously.
21 Jul 2025 · 1 min read
I explore why bigger isn't always better when it comes to data in AI — and why, in healthcare especially, the real problem is data quality, not quantity. Curated, structured, interoperable data is what will make trustworthy clinical AI possible.
17 Jun 2025 · 1 min read
I share key learnings from the AIspotlight at HLTHEurope2025 on federated data and learning collaboration, where speakers from Roche, Charité, and beyond made the case for combining insights across institutions. A recurring theme: this shift in how we interact with health data requires clearer explanation and specific use cases for stakeholders.